Abstract
The rat model of endocarditis is a well established experimental protocol which closely approximates human native valve endocarditis. The rat model of endocarditis has been used to examine the role of particular streptococcal virulence factors, to assess immunoprotective strategies, and to evaluate the efficacy of selected antibiotic treatment regimens for streptococcal endocarditis. Like humans, rats are generally susceptible to endocarditis only if the cardiac valves have been damaged. In the rat model of endocarditis, damage to the aortic valve and sterile vegetation formation is accomplished by insertion of a polyethylene catheter through the carotid artery into the left ventricle. Following catheter insertion, an inoculum of streptococci are injected intravenously. Vegetations removed from the heart valves during thoracotomy of euthanized animals are qualitatively cultured for streptococcal infection. The method, including investigator safety considerations, is described in detail.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Baddour LM, Christensen GD, Lowrance JH, Simpson WA (1989). Pathogenesis of experimental endocarditis. Rev Infect Dis 11 (3): 452–463.
Burkhart JE, Stobbe TJ (1990). Real-time measurement and control of waste anesthetic gases during veterinary surgery. Am Ind Hyg Assoc J 51: 640–645.
Burnette-Curley D, Wells V, Viscount H, Munro CL, Fenno JC, Fives-Taylor P, Macrina FL (1995). FimA, a major virulence factor associated with Streptococcus parasanguis endocarditis. Infect Immun 63: 46694674.
Carbon C (1993). Experimental endocarditis: A review of its relevance to human endocarditis. J Antimicrob Chemother 31 (Suppl D): 71–85.
Douglas CW, Brown PR, Preston FE (1990). Platelet aggregation by oral streptococci. FEMS Microbiol Lett 60: 63–67.
Ford I, Douglas CW, Preston FE, Lawless A, Hampton KK (1993). Mechanisms of platelet aggregation by Streptococcus sanguis, a causative organism in infective endocarditis. Br J Haematol 84: 95–100.
Herzberg MC, Gong K, MacFarlane GD, Erickson PR, Soberay AH, Krebsbach PH, Manjula G, Schilling K, Bowen WH (1990). Phenotypic characterization of Streptococcus sanguis virulence factors associated with bacterial endocarditis. Infect Immun 58: 515522.
Manning JE, Geyelin AJ, Ansmits LM, Oakey HJ, Knox KW (1994). A comparative study of the aggregation of human, rat and rabbit platelets by members of the Streptococcus sanguis group. J Med Microbiol 41: 10–13.
Manning JE, Hume EB, Hunter N, Knox KW (1994). An appraisal of the virulence factors associated with streptococcal endocarditis. J Med Microbiol 40: 110–4.
Munro CL, Macrina FL (1993). Sucrose-derived exopolysaccharides of Streptococcus mutans V403 contribute to infectivity in endocarditis. Mol Microbiol 8: 133–142.
Santoro J, Levinson ME (1978). Rat model of experimental endocarditis. Infect Immun 19: 915–918.
Stimpel TM, Gershey EL (1991). Selecting anesthetic agents for human safety and animals recovery surgery. FASEB J 5: 2099–2104.
Sullam PM, Costerton JW, Yamasaki R, Dazin PF, Mills J (1993). Inhibition of platelet binding and aggregation by streptococcal exopolysaccharide. J Infect Dis 167: 1123–1130.
Sullam PM, Frank U, Yeaman MR, Tauber MG, Bayer AS, Chambers HF (1993). Effect of thrombocytopenia on the early course of streptococcal endocarditis. J Infect Dis 168: 910–914.
Tart RC, van de Rijn I (1991). Analysis of adherence of Streptococcus defectivus and endocarditis-associated streptococci to extracellular matrix. Infect Immun 59: 857–862.
Viscount HB, Munro CL, Burnette-Curley D, Peterson DL, Macrina FL (1997) Immunization with FimA protects against Streptococcus parasanguis endocarditis in rats. Infect Immun 65: 994–1002.
Wells VD, Munro CL, Sulavik MC, Clewell DB, Macrina FL (1993). Infectivity of a glucan synthesis-defective mutant of Streptococcus gordonii ( Challis) in a rat endocarditis model. FEMS Microbiol Lett 112: 301–305.
Willcox MD (1995). Potential pathogenic properties of members of the `Streptococcus milleri’ group in relation to the production of endocarditis and abscesses. J Med Microbiol 43: 405–410.
Wu T, Yeaman MR, Bayer AS (1994). In vitro resistance to platelet microbicidal protein correlates with endocarditis source among bacteremic staphylococcal and streptococcal isolates. Antimicrob Agents Chemother 38: 729–732.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Munro, C.L. (1998). The rat model of endocarditis. In: Fives-Taylor, P.M., LeBlanc, D.J. (eds) Methods for studying the genetics, molecular biology, physiology, and pathogenesis of the streptococci. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-2258-2_22
Download citation
DOI: https://doi.org/10.1007/978-94-017-2258-2_22
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-5262-9
Online ISBN: 978-94-017-2258-2
eBook Packages: Springer Book Archive